Ref. ID 83055
Añadir a mis citas
Mamounas EP,
et al.
Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: Intention-to-treat analysis of the National Surgical Adjuvant Breast and Bowel Project B-33
Journal of Clinical Oncology: official journal of the American Society of Clinical Oncology (J Clin Oncol)
2008
Volumen 26 página(s) 261965
Sin resumen.
ANASTROZOL,
CÁNCER DE MAMA,
ECC,
EFECTOS INDESEADOS,
EFICACIA,
EI,
ENSAYO CLÍNICO,
EXEMESTANO,
GINECOLOGÍA,
INHIBIDORES DE LA AROMATASA,
LETROZOL,
MODULADORES DEL RECEPTOR ESTROGÉNICO,
MUJER,
ONCOLOGÍA,
POSTMENOPÁUSICA,
PRONÓSTICO,
QUIMIOTERÁPICOS ANTINEOPLÁSICOS,
RCT,
SUPERVIVENCIA,
TAMOXIFENO,
TRATAMIENTO
@SIETES7
Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: Intention-to-treat analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 ID83055
